Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Trypanosome purine transporter system is a critical survival mechanism for protozoan parasites of the genus Trypanosoma, which are auxotrophic for purines and cannot synthesize them de novo [Landfear, 2004]. These parasites rely entirely on salvaging purines from the host's environment using specialized transporters, primarily categorized into P1 and P2 types [Mäser, 1999]. The P2 transporter, encoded by the TbAT1 gene in Trypanosoma brucei, is particularly significant as it facilitates the high-affinity uptake of adenosine and adenine [Geiser, 2005]. Beyond its physiological role, the P2 transporter serves as the primary route of entry for several essential trypanocidal drugs, including melarsoprol and pentamidine [Barrett, 2007]. Mutations or deletions in these transporter genes are major drivers of drug resistance in clinical settings, as the parasite can survive by relying on alternative salvage pathways while excluding the toxins [Matovu, 2003]. The P1 transporters, by contrast, handle a broader range of substrates including inosine, guanosine, and hypoxanthine, ensuring metabolic flexibility [De Koning, 2001]. Understanding the substrate specificity and kinetics of these transporters is vital for developing next-generation nucleoside analogs that can bypass resistance mechanisms [Berg, 2010]. This system represents a classic example of how metabolic dependencies in pathogens can be exploited for targeted drug delivery [Fairlamb, 2003].
Facilitated diffusion of purine nucleosides and nucleobases; selective uptake of trypanocidal drugs into the parasite cytoplasm via high-affinity transport proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypanosome purine transporter system (ENT).